Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
Clinical trial NCT03980041 · COMPLETED
Trial details
- NCT number
- NCT03980041
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-25
- Primary completion
- 2020-11-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.